Analysing the molecular and biochemical mechanisms disturbing the complex network of communication is key to our understanding of the pathophysiology of the functional GI disorders. Together with ESNM we have prepared an exciting webinar series under the topic: Microbiota and Gut-Brain Connection: A new Frontier in Neurogastroenterology. This free resource is a great opportunity to hear leading worldwide experts presenting the most recent findings on this topic.
Gut Microbiota Research & Practice is a section dedicated to promoting knowledge-sharing and debate among researchers, scientists and healthcare professionals. You will find a selection of discussions about articles from scientific literature as well as other content including interviews with experts, event reports, and special publications.
The role of probiotics on respiratory and gastrointestinal tract infections in healthy people: what science says today?
29 Mar 2021by Andreu Prados
The role of gut microbiota in shaping immune responses has led scientists to explore the modulation of the immune system as a mechanism underlying the health benefits of probiotics. A new systematic review and meta-analysis of 9 randomized clinical trials suggest probiotics may reduce the incidence of respiratory and gastrointestinal tract infections in generally healthy children and adults.
Does functional abdominal pain have an organic explanation? Gut-localized immune responses offer new clues for patients with functional gastrointestinal disorders
8 Mar 2021by Rene van den Wijngaard
Abdominal pain affects a huge amount of people nowadays, though its underlying mechanisms are not always understood. New findings in mice and humans reveal that localized immune responses against harmless foods might be involved in persistent “functional” abdominal pain.
Is it time to consider next-generation beneficial microbes for tackling obesity?
15 Feb 2021by Andreu Prados
Is it time to consider next-generation beneficial microbes for tackling obesity? APC Microbiome Ireland researchers identify Bifidobacterium longum APC1472 as a promising candidate
2020 at a glance: A year of important scientific progress in gut microbiome research
1 Feb 2021by GMFH Editing Team
In 2020, we saw important scientific advances in our understanding of how the gut microbiome contributes to human health beyond the gastrointestinal milieu. Discover the year’s breakthroughs in this “2020 Year at a glance” report.
Should dietary guidelines advise consumers to deliberately include safe microorganisms in their diets?
18 Jan 2021by Andreu Prados
While for almost all of human evolution our food and water have contained large numbers of microorganisms, the industrialized human diet contains low microbial numbers. So are we ready to recommend a specific daily intake of microbes?
The pharmacist inside us: what are the implications of drug-gut microbiome interactions in the clinical setting?
4 Jan 2021by GMFH Editing Team
Beyond antibiotics, a wide range of commonly used non-antibiotic drugs can affect the gut microbiome. In addition, the gut microbiome can also influence an individual’s response to drugs by affecting their efficacy and safety. What are the implications of the bidirectional interaction between non-antibiotic drugs and the gut microbiome in the clinical setting?
What major scientific breakthroughs have been made in gut microbiome science in 2020?
28 Dec 2020by Andreu Prados
Although the COVID-19 pandemic has shifted the focus of research for scientists worldwide, major breakthroughs in gut microbiome science have been made in 2020. In this last post of the year, we bring you articles from our blog that cover the major advances in the gut microbiome in 2020, from bench to bedside.
What is the role of nutrition in immunity and host susceptibility to COVID-19?
21 Dec 2020by Andreu Prados
The metabolic activity of immune cells is enhanced after a viral infection, such as the one driven by COVID-19. Dietary approaches that support a healthy gut microbiome can benefit the immune system and ensure a good nutritional status that would help the host deal with pathogens.
Fecal bacterial protease activity may indicate progression to ulcerative colitis
14 Dec 2020by Heather Galipeau
Many studies have reported changes in gut microbiome composition in patients with inflammatory bowel disease, including ulcerative colitis, when compared with healthy individuals. While that clearly raises the question about the key role played by gut microbes in IBD pathogenesis, we have yet to pinpoint the causative microbes and their mechanisms.